Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Livercellgram in Alcoholic Liver Cirrhosis
NCT01875081Phase 2Completed
- Sponsor
- Pharmicell Co., Ltd.
- Start
- Nov 2012
- Primary completion
- Mar 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of Cellgram-LC in alcoholic liver cirrhosis, sponsored by Pharmicell Co., Ltd.. Started Nov 2012; status: completed.
02
Drugs
Cellgram-LC
03
Conditions
alcoholic liver cirrhosis
Beyond the preview
Go deeper on NCT01875081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875081.